# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
- Reuters
Portage Biotech (NASDAQ:PRTG) reported quarterly losses of $(1.58) per share. This is a 76.38 percent increase over losses of $...
The decrease was primarily due to lower non-cash losses on impairment related to the Company's identifiable intangible asse...